FIELD: medicine.
SUBSTANCE: invention refers to experimental medicine, namely to oncology, and can be used for improvement of practical approaches to cancer treatment. After formation of melanoma B16 in animals, 7 days after tumour transplantation, an injectable aqueous solution of azoximer bromide is injected intraperitoneally. Preparation is administered in dose of 100 mcg/mouse twice a week in a total course of 10 injections.
EFFECT: method will allow extending the most modern means of therapy of oncological diseases, increasing survival rate and reducing tumour volume in treating melanoma B16.
1 cl, 1 dwg, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SUPPRESSING THE GROWTH OF B16 MELANOMA IN LABORATORY ANIMALS | 2022 |
|
RU2784443C2 |
| PHARMACEUTICAL COMPOSITION BASED ON PALLADIUM COMPOUND | 2015 |
|
RU2613305C2 |
| METHOD OF TREATING MELANOMA IN VIVO | 2023 |
|
RU2824428C2 |
| METHOD FOR PREVENTING THE DEVELOPMENT OF MYOCARDIAL INFARCTION IN MICE WITH MELANOMA THAT DEVELOPED AGAINST THE BACKGROUND OF CHRONIC NEUROGENIC PAIN | 2022 |
|
RU2786322C1 |
| METHOD FOR INCREASING THE EFFECTIVENESS OF IONIZING RADIATION ON MELANOMA | 2021 |
|
RU2774032C1 |
| METHOD OF PHOTODYNAMIC THERAPY OF TRANSPLANTED ECTODERMAL TUMOR OF MELANOMA B16 OF MICE | 2020 |
|
RU2724867C2 |
| COMBINED ANTICANCER THERAPY AND PHARMACEUTICAL COMPOSITIONS THEREFOR | 2005 |
|
RU2396960C2 |
| METHOD OF INCREASING THE EFFICIENCY OF PROTON THERAPY ON MELANOMA STEM CELLS | 2022 |
|
RU2798733C2 |
| AGENT WITH ANTITUMOUR AND ANTIMETASTATIC ACTIVITY, ANTI-INFLAMMATORY AND ANTIALLERGIC ACTION | 2018 |
|
RU2686672C1 |
| APPLICATION OF COMPOUND 2-[3-(2-CHLOROETHYL)-3-NITROSOUREIDO]-1.3-PROPANEDIOL FOR TREATMENT OF EHRLICH CARCINOMA, SARCOMA 37, LIO-1 LYMPHOSARCOMA, MELANOMA B16, TRANSPLANTED INTO LOWER EYELID OF MICE IN EXPERIMENT | 2020 |
|
RU2752083C1 |
